Physician's Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 9 to 13, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Statins Tied to Lower In-Hospital COVID-19 Mortality Risk
FRIDAY, Nov. 13, 2020 (HealthDay News) -- Treatment with statins prior to and during a COVID-19-related hospitalization is associated with lower COVID-19-related in-hospital mortality, according to a study published online Nov. 2 in the European Heart Journal: Cardiovascular Pharmacotherapy.
ACR: Incidence of COVID-19 Low in Patients With Rheumatic Disease
FRIDAY, Nov. 13, 2020 (HealthDay News) -- Patients with rheumatic disease have a low incidence of COVID-19 and most have mild disease, according to research presented at ACR Convergence, the annual meeting of the American College of Rheumatology, held virtually from Nov. 5 to 9.
Mental Health ED Visits in Children Up Mid-March to October 2020
FRIDAY, Nov. 13, 2020 (HealthDay News) -- From mid-March to October 2020, there was an increase in the proportion of mental health-related emergency department visits among children and adolescents, according to research published in the Nov. 13 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
U.S. Nursing Homes Seeing Increase in New COVID-19 Cases
THURSDAY, Nov. 12, 2020 (HealthDay News) -- Nursing homes are seeing an increase in new COVID-19 cases, paralleling an increase in the general U.S. population, according to a report published online Nov. 10 by the American Health Care Association and National Center for Assisted Living.
AHA: Patient CPR Outcomes Similar With COVID-19 Precautions
THURSDAY, Nov. 12, 2020 (HealthDay News) -- For patients receiving cardiopulmonary resuscitation, outcomes during COVID-19 were similar to those in 2019, according to a study presented at the American Heart Association Resuscitation Science Symposium 2020, to be held virtually from Nov. 14 to 16 as part of the annual meeting of the American Heart Association.
COVID-19 at Forefront of IDWeek Discussions
THURSDAY, Nov. 12, 2020 (HealthDay News) -- Emerging COVID-19 science, including epidemiology, treatments, vaccines, and post-COVID-19 syndrome took center stage at this year's IDWeek, the annual meeting of infectious disease experts worldwide, held virtually from Oct. 21 to 25. HD Live! sat down with IDWeek chairs Inger Damon, M.D., director of the U.S. Centers for Disease Control and Prevention Division of High-Consequence Pathogens and Pathology, and Tom Talbot, M.D., professor of medicine at the Vanderbilt University School of Medicine in Nashville, Tennessee, to break down the key takeaways of this year's meeting.
9 Percent Readmitted After Index COVID-19 Hospitalization
THURSDAY, Nov. 12, 2020 (HealthDay News) -- Among patients surviving an index COVID-19 hospitalization, 9 percent are readmitted within two months of discharge, according to research published in the Nov. 9 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
NHLBI Trial Concludes No Benefit for Hydroxychloroquine in COVID-19
THURSDAY, Nov. 12, 2020 (HealthDay News) -- Hydroxychloroquine is not beneficial for adults hospitalized with COVID-19, according to the formal conclusion of a study funded by the U.S. National Heart, Lung, and Blood Institute and published online Nov. 9 in the Journal of the American Medical Association.
Many at Risk for Severe COVID-19 Have Essential Jobs
TUESDAY, Nov. 10, 2020 (HealthDay News) -- Between 56.7 and 74.3 million U.S. adults are at increased risk for severe COVID-19 and are either themselves an essential worker or live with one, according to a research letter published online Nov. 9 in JAMA Internal Medicine.
Intentional Violent Injuries Up During Peripandemic Period
TUESDAY, Nov. 10, 2020 (HealthDay News) -- The proportion of intentional violent injuries increased during the peripandemic months, especially from firearms, according to a study published online Nov. 6 in the Journal of the American College of Surgeons.
Antibody Treatment Approved for Emergency Use Against Early COVID-19
TUESDAY, Nov. 10, 2020 (HealthDay News) -- Eli Lilly's experimental antibody treatment for COVID-19 was given emergency approval by the U.S. and Food Administration on Monday.
COVID-19 Infection Higher Among Support Staff Than Doctors, Nurses
TUESDAY, Nov. 10, 2020 (HealthDay News) -- Support staff in health care settings have higher COVID-19 infection rates than physicians and nurses, according to a study published online Oct. 31 in Open Forum Infectious Diseases.
Preexisting Tinnitus May Be Exacerbated by COVID-19
MONDAY, Nov. 9, 2020 (HealthDay News) -- Preexisting tinnitus may be exacerbated by COVID-19, although more than half of patients experience no change in symptoms, according to a study published online Nov. 5 in Frontiers in Public Health.
Pfizer COVID-19 Vaccine Reaches 90 Percent Effectiveness in Early Analysis
MONDAY, Nov. 9, 2020 (HealthDay News) -- A new vaccine developed by Pfizer and the German biotechnology firm BioNTech was more than 90 percent effective at protecting people from COVID-19, an interim analysis released Sunday shows.
Hospital Stays After Delivery Shorter With Pandemic Protocols
MONDAY, Nov. 9, 2020 (HealthDay News) -- Although maternal and newborn length of stay in the hospital after delivery is significantly shorter following policy modifications put in place due to the COVID-19 pandemic, no increases in the rate of adverse maternal or neonatal outcomes have been observed, according to a study published in the November issue of the American Journal of Obstetrics and Gynecology: Maternal-Fetal Medicine.